In 2020, the Cancer Institute NSW presented the annual NSW Premier’s Awards for Outstanding Cancer Research. These awards honoured the achievements of the individuals and teams that work across the cancer research sector to lessen the impact of cancer.
In response to the unique challenges brought on by the COVID-19 pandemic, the NSW Premier’s Awards were hosted online. One award was announced every day on social media from 23–27 November.
Across our digital channels, we dedicated the entire week to cancer research in NSW to share the incredible work of our award winners and celebrate the best and brightest in our state.
More information
One award was announced every day across the week on our social channels:
- Monday, 23 Nov 2020 - Wildfire Highly Cited Publication winner announcement
- Tuesday, 24 Nov 2020 - Outstanding Cancer Clinical Trials Unit winner announcement
- Wednesday, 25 Nov 2020 - Outstanding Cancer Research Fellow – Early Career Fellow winner announcement
- Thursday, 26 Nov 2020 - Outstanding Cancer Research Fellow – Career Development Fellow winner announcement
- Friday, 27 Nov 2020 - Outstanding Cancer Researcher of the Year winner announcement
The following four awards were presented to those outstanding researchers working to lessen the impact of cancer in NSW:
- Outstanding Cancer Researcher of the Year
- Wildfire Highly Cited Publication
- Outstanding Cancer Research Fellow
- Outstanding Cancer Clinical Trials Unit
Awards by nomination
Outstanding Cancer Researcher of the Year
The Outstanding Cancer Researcher of the Year Award recognises an individual researcher who has made an active, outstanding, sustained contribution to any field of cancer research in NSW; has a record of substantive and noteworthy publications; and has supported, developed and mentored cancer researchers.
The successful award recipient received a prize of $50,000 to assist their research endeavours, and a commemorative award.
This is an individual award. Nominations may be made by an individual who is or has been affiliated with any institution involved in cancer research or cancer medicine in NSW. Nominees cannot nominate themselves for this award.
Wildfire Highly Cited Publication
The Wildfire Highly Cited Publication Award recognises a NSW researcher, or team of researchers, who has made a significant difference to cancer care or research practice. This award will be presented to an individual, or research team, for a highly cited publication.
The recipient's contributions will have had a lasting impact on the cancer field and can demonstrate sustained progress against cancer.
The successful award recipient(s) received a prize of $10,000 to assist their research endeavours, and a commemorative award.
This is an individual award or team award. Nominations may be made by an individual, or research team who is or has been affiliated with any institution involved in cancer research or cancer medicine in NSW. Nominees can nominate themselves or their team for this award.
Awards by selection
Outstanding Cancer Research Fellow
The Outstanding Cancer Research Fellow Award will be presented to an early career researcher who has demonstrated exceptional research progress over the previous calendar year.
The Outstanding Cancer Research Fellow is assessed by a review of the annual progress reports and final reports as submitted in 2020.
The shortlisted Fellows will be assessed by an independent, external Review Committee of the Cancer Institute NSW.
The successful award recipient received a prize of $10,000 towards their research endeavours, and a commemorative award.
Outstanding Cancer Clinical Trials Unit
Making NSW a destination of choice for cancer clinical trials is one of the strategies of the NSW Cancer Plan.
The Cancer Institute NSW Clinical Trials Program supports Clinical Trial Units by funding Local Health Districts, Speciality Health Networks and Private Institutions for enrolments to investigator initiated cancer clinical trials and works collaboratively to develop a strategic approach for the selection and implementation of cancer clinical trials relevant to their population.
The best performing Cancer Clinical Trial Unit is selected for this award through the data held in the Cancer Institute NSW Clinical Trials Portal for the period of 1 July 2019 to 30 June 2020.
The successful Clinical Trial Unit received a prize of $10,000 towards the activities of the Cancer Clinical Trials Unit, and a commemorative award.
